首页|期刊导航|老年心脏病学杂志(英文版)|Association of cardiometabolic multimorbidity with all-cause and cardiovascular disease mortality among Chinese hypert-ensive patients

Association of cardiometabolic multimorbidity with all-cause and cardiovascular disease mortality among Chinese hypert-ensive patientsOA北大核心

Association of cardiometabolic multimorbidity with all-cause and cardiovascular disease mortality among Chinese hypert-ensive patients

Luo-Xi XIAO;Na YANG;Li-Zhen HAN;Zhao YANG;Ping-Ping JIA;Yue QI;Jing LIU;Zi-Yu WANG;Jiang-Tao LI;Hai-Mei WANG;Yi-Ming HAO;Pan ZHOU;Yu-Lin HUANG;Qiu-Ju DENG;Yong-Chen HAO

Center for Clinical and Epidemiologic Research,Beijing Anzhen Hospital,Capital Medical University,Beijing Institute of Heart,Lung and Blood Vessel Diseases,Beijing Municipal Key Laboratory of Clinical Epidemiology,Beijing,ChinaCenter for Clinical and Epidemiologic Research,Beijing Anzhen Hospital,Capital Medical University,Beijing Institute of Heart,Lung and Blood Vessel Diseases,Beijing Municipal Key Laboratory of Clinical Epidemiology,Beijing,ChinaCenter for Clinical and Epidemiologic Research,Beijing Anzhen Hospital,Capital Medical University,Beijing Institute of Heart,Lung and Blood Vessel Diseases,Beijing Municipal Key Laboratory of Clinical Epidemiology,Beijing,ChinaCenter for Clinical and Epidemiologic Research,Beijing Anzhen Hospital,Capital Medical University,Beijing Institute of Heart,Lung and Blood Vessel Diseases,Beijing Municipal Key Laboratory of Clinical Epidemiology,Beijing,ChinaCenter for Clinical and Epidemiologic Research,Beijing Anzhen Hospital,Capital Medical University,Beijing Institute of Heart,Lung and Blood Vessel Diseases,Beijing Municipal Key Laboratory of Clinical Epidemiology,Beijing,ChinaCenter for Clinical and Epidemiologic Research,Beijing Anzhen Hospital,Capital Medical University,Beijing Institute of Heart,Lung and Blood Vessel Diseases,Beijing Municipal Key Laboratory of Clinical Epidemiology,Beijing,ChinaCenter for Clinical and Epidemiologic Research,Beijing Anzhen Hospital,Capital Medical University,Beijing Institute of Heart,Lung and Blood Vessel Diseases,Beijing Municipal Key Laboratory of Clinical Epidemiology,Beijing,ChinaCenter for Clinical and Epidemiologic Research,Beijing Anzhen Hospital,Capital Medical University,Beijing Institute of Heart,Lung and Blood Vessel Diseases,Beijing Municipal Key Laboratory of Clinical Epidemiology,Beijing,ChinaCenter for Clinical and Epidemiologic Research,Beijing Anzhen Hospital,Capital Medical University,Beijing Institute of Heart,Lung and Blood Vessel Diseases,Beijing Municipal Key Laboratory of Clinical Epidemiology,Beijing,ChinaCenter for Clinical and Epidemiologic Research,Beijing Anzhen Hospital,Capital Medical University,Beijing Institute of Heart,Lung and Blood Vessel Diseases,Beijing Municipal Key Laboratory of Clinical Epidemiology,Beijing,ChinaCenter for Clinical and Epidemiologic Research,Beijing Anzhen Hospital,Capital Medical University,Beijing Institute of Heart,Lung and Blood Vessel Diseases,Beijing Municipal Key Laboratory of Clinical Epidemiology,Beijing,ChinaCenter for Clinical and Epidemiologic Research,Beijing Anzhen Hospital,Capital Medical University,Beijing Institute of Heart,Lung and Blood Vessel Diseases,Beijing Municipal Key Laboratory of Clinical Epidemiology,Beijing,ChinaCenter for Clinical and Epidemiologic Research,Beijing Anzhen Hospital,Capital Medical University,Beijing Institute of Heart,Lung and Blood Vessel Diseases,Beijing Municipal Key Laboratory of Clinical Epidemiology,Beijing,ChinaCenter for Clinical and Epidemiologic Research,Beijing Anzhen Hospital,Capital Medical University,Beijing Institute of Heart,Lung and Blood Vessel Diseases,Beijing Municipal Key Laboratory of Clinical Epidemiology,Beijing,ChinaCenter for Clinical and Epidemiologic Research,Beijing Anzhen Hospital,Capital Medical University,Beijing Institute of Heart,Lung and Blood Vessel Diseases,Beijing Municipal Key Laboratory of Clinical Epidemiology,Beijing,China

《老年心脏病学杂志(英文版)》 2024 (2)

211-218,8

This study was supported by the National Key Re-search and Development Program of China(2022YFC 3602501)and the Pfizer Inc.(New York,USA)offices in Beijing,China.All authors had no conflicts of interest to disclose.

10.26599/1671-5411.2024.02.003

评论